Gao Y.,The Navy General Hospital |
Peng X.-J.,The Navy General Hospital |
Yang L.-J.,PLA Air Force Aviation University |
Cui B.,The Navy General Hospital |
And 2 more authors.
International Eye Science | Year: 2013
AIM: To study the influential factors of the contrast sensitivity function (CSF), we tested and investigated the CSF of navy pilots. METHODS: Totally 58 pilots (116 eyes) were examined by CSF under the nighttime, nighttime & periglare, daytime, daytime & periglare conditions for 5 spacial frequencies with OPTEC6500 Vision Tester. RESULTS: From mean diagram of curves, the peak of CSF under the nighttime, nighttime & periglare conditions was at 3-6 c/d, daytime, daytime & periglare conditions was at 6 c/d. CONCLUSION: The distant CSF is better than the near CSF in navy pilots, the binoculus CSF is better than that of the single eye. The spatial characteristics of CSF in navy pilots were reflected by present study.
Liu P.,The Navy General Hospital |
Jin X.,The Navy General Hospital |
Lv H.,The Navy General Hospital |
Li J.,Shanghai University |
And 3 more authors.
In Vitro Cellular and Developmental Biology - Animal | Year: 2014
To investigate the effects of icaritin, an active ingredient extracted from Epimedium Sagittatum (Sieb. et Zucc.), on CCl4-induced liver injury and its possible mechanisms. Hepatocytes isolated from Sprague-Dawley male rats were treated with 3 mmol/L CCl4 for 24 h to induce acute liver cell injury, then icaritin (0.1, 1, 10, 100 μmol/L, respectively) was administrated to the cells, and estrogen receptor antagonist ICI182,780 (1 μmol/L) was co-treated with 10 μmol/L icaritin. Biochemical parameters (alanine aminotransferase (ALT), aspartate aminotransferase (AST), malondialdehyde (MDA), and superoxide dismutase (SOD)) and cell apoptosis were detected to evaluate the injury degree. Protein expressions of Bax, Bcl-2, liver fatty acid-binding protein (L-FABP), and peroxisome proliferator-activated receptor-α (PPAR-α) as well as reactive oxygen species (ROS) generation were determined by western blot. Icaritin alleviated CCl4-induced liver cell injury in a concentration-dependent manner and 10 μmol/L was the optimal concentration. Icaritin (10 μmol/L) significantly reduced activities of ALT, AST in cell culture medium and MDA level of the impaired liver cells, but increased the intercellular SOD activity. The apoptotic rate of the impaired liver cells was also decreased by icaritin (10 μmol/L) treatment. Icaritin might exert antioxidative and anti-apoptotic functions via estrogen-like effect, as the ratio of Bcl-2/Bax was significantly increased, while protein expressions of L-FABP and PPAR-α were markedly increased, and this function was blocked by the estrogen receptor antagonist ICI182,780 efficiently. Icaritin may be a promising drug candidate for acute liver injury benefiting from the antioxidative and anti-apoptotic functions via estrogen-like effect. © 2014, The Society for In Vitro Biology.
Li M.X.,The Navy General Hospital |
Yu Y.W.,The Navy General Hospital |
Zhang Z.Y.,The Navy General Hospital |
Zhao H.D.,The Navy General Hospital |
Xiao F.L.,The Navy General Hospital
Genetics and Molecular Research | Year: 2015
This study aimed to investigate the effects of administration of low-dose cyclosporine A (CsA) alone and the combination of low-dose CsA and a low-dose hormone for the treatment of elderly patients with membranous nephropathy. We divided 27 patients into two groups as follows: low-dose CsA group (group A) and the group receiving a combination of a low-dose hormone and low-dose CsA (group B). The treatment and follow-up times were ≥6 months. We observed no difference in gender, age, serum creatinine levels, estimated glomerular filtration rate (eGFR), and 24-h urinary protein levels between the two groups before treatment; in addition, the rates of complete and partial remission were not different 6 months after treatment. The rate of complications in group B was higher than that in group A (84.6 vs 35.7%, respectively; t = 0.018). While the pretreatment eGFR of patients who achieved remission was significantly higher than that of patients who did not achieve remission, the 24-h urinary protein levels and incidence of hypertension were significantly lower than those of patients who did not achieve remission (t = 0.042, 0.035 and 0.043, respectively). The efficacy of administration of low-dose CsA alone and in combination with a low-dose hormone was similar; the efficacy was related to eGFR, urinary protein levels, and the incidence of hypertension before the treatment. The side effects of administration of CsA alone were significantly lower than those of the combination treatment. ©FUNPEC-RP.